Ensuring that patients are fully informed about their treatment options, including the benefits and risks of medications like Ozempic , is essential for fostering trust and ensuring the efficacy of treatment plans
It currently makes three drugs that contain semaglutide, including: Wegovy, a once-weekly injectable medicine for weight loss and cardiovascular risk reduction Ozempic, a once-weekly injectable medicine for Type 2 diabetes and cardiovascular risk reduction, often prescribed off-label (for a non-FDA-approved use) for weight loss Rybelsus, a daily oral medicine for managing blood sugar levels in people with Type 2 diabetes, and sometimes prescribed off-label for weight loss These three brand-name medicines are the only FDA-approved semaglutide products
While clinically effective, GLP-1s are complicated
Practical differences come down to insurance coverage, cost, and availability
Understanding the relationship between semaglutide units and milligrams helps you maintain accurate dosing